CNMDNYSE

CONMED Corp

Alert me on CNMD

Insider buys, 6 months

Congress trades, 6 months

Signals, 6 months

Six months

After each filing

Nov 24, 2025 Sale Glaze Richard Insider

1 week

+1.7%S&P +1.9%

1 month

−7.2%S&P +3.5%

3 months

+5.9%S&P +3.4%

6 months

−18.0%S&P +13.5%

Nov 8, 2025 Sale Garner Todd W Insider

1 week

−5.3%S&P −2.3%

1 month

−11.2%S&P +0.9%

3 months

−3.7%S&P +1.8%

6 months

−19.1%S&P +9.6%

Sep 15, 2025 Sale Farkas Charles Insider

1 week

−3.5%S&P +1.2%

1 month

−14.0%S&P +0.5%

3 months

−21.2%S&P +3.4%

6 months

−27.9%S&P +2.1%

Every purchase and sale on this ticker reported by a member of Congress or an insider, measured from the close of the first trading day after it became public to the close 1 week, 1 month, 3 months and 6 months later, each beside the S&P over the same days.

Filings for CNMD

40 held · newest 540 held · newest 2

Loading the filings.

See all 40 filings for CNMD

Aeon news and offers by email

New sources, new features and offers like our founding price. A few times a month at most. Stop any time.

Signal history

No signal for this ticker yet. A signal is written when insider buying here scores one dot or more.

Stakes

Mar 31, 2026 Schedule 13G

Vanguard Capital Management: 5.3%, 1,619,070 shares

Mar 31, 2026 Schedule 13G

Vanguard Portfolio Management: 6.9%, 2,120,886 shares

Mar 13, 2026 Schedule 13G, amended

The Vanguard Group: 0%, 0 shares

Sep 30, 2025 Schedule 13G, amended

Capital Research Global Investors: 3.3%, 1,032,733 shares

Schedule 13D is filed within 5 business days of crossing 5 percent by an investor who may seek to influence the company. Schedule 13G is filed by a passive holder, and a large institution has up to 45 days after the quarter end.

Government contracts, last 12 months

Awards of $10M and up, from USAspending · context, not a signal

No contracts of $10M or more in the last 12 months.

Lobbying

Last four quarters

No lobbying reports on file.